Techno Medica Co., Ltd. (6678) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Mizuho Medy Co., Ltd.

Shofu, Inc.

Rion Co., Ltd.

FRANCE BED HOLDINGS CO., LTD.

Medikit Co., Ltd.

Techno Medica Co., Ltd.

Eiken Chemical Co., Ltd.

CYBERDYNE, Inc.

Seed Co., Ltd. /7743/

Japan Medical Dynamic Marketing, Inc.

ReproCELL, Inc.

Why is Techno Medica Co., Ltd. ?

Company has very low debt and has enough cash to service the debt requirements

Poor long term growth as Net Sales has grown by an annual rate of 0.19% and Operating profit at 0.67% over the last 5 years

With a growth in Operating Profit of 87.31%, the company declared Very Positive results in Dec 25

The company has declared positive results in Jan 70 after 3 consecutive negative quarters
NET SALES(Q) At JPY 3,134.41 MM has Grown at 34.51%
PRE-TAX PROFIT(Q) At JPY 566.81 MM has Grown at 95.12%
NET PROFIT(Q) At JPY 372.65 MM has Grown at 81.77%

With ROE of 6.89%, it has a very attractive valuation with a 1.10 Price to Book Value

The stock is trading at a premium compared to its peers' average historical valuations
Over the past year, while the stock has generated a return of 31.33%, its profits have fallen by -26.4%

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Techno Medica Co., Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Techno Medica Co., Ltd. for you?

Low Risk, Medium Return

Absolute

Risk Adjusted

Volatility

Techno Medica Co., Ltd.

31.33%

1.17

28.56%

Japan Nikkei 225

36.73%

1.30

28.24%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

0.19%

EBIT Growth (5y)

0.67%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.63

Sales to Capital Employed (avg)

0.71

Tax Ratio

23.88%

Dividend Payout Ratio

46.87%

Pledged Shares

Institutional Holding

ROCE (avg)

34.72%

ROE (avg)

7.90%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.10

EV to EBIT

5.24

EV to EBITDA

4.87

EV to Capital Employed

1.28

EV to Sales

0.69

PEG Ratio

Dividend Yield

ROCE (Latest)

24.41%

ROE (Latest)

6.89%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bollinger Bands

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Bullish

Dow Theory

Mildly Bullish

No Trend

OBV

No Trend

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

9What is working for the Company

NET SALES(Q)

At JPY 3,134.41 MM has Grown at 34.51%

PRE-TAX PROFIT(Q)

At JPY 566.81 MM has Grown at 95.12%

NET PROFIT(Q)

At JPY 372.65 MM has Grown at 81.77%

-3What is not working for the Company

RAW MATERIAL COST(Y)

Grown by 7.08% (YoY

CASH AND EQV(HY)

Lowest at JPY 17,553.1 MM

DEBT-EQUITY RATIO (HY)

Highest at -60.42 %

Here's what is working for Techno Medica Co., Ltd.

Net Sales

At JPY 3,134.41 MM has Grown at 34.51%

Year on Year (YoY)

MOJO Watch

Near term sales trend is very positive

Net Sales (JPY MM)

Pre-Tax Profit

At JPY 566.81 MM has Grown at 95.12%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (JPY MM)

Net Profit

At JPY 372.65 MM has Grown at 81.77%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is positive

Net Profit (JPY MM)

Here's what is not working for Techno Medica Co., Ltd.

Cash and Eqv

Lowest at JPY 17,553.1 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents

Debt-Equity Ratio

Highest at -60.42 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Raw Material Cost

Grown by 7.08% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales